glp-1 cardiovascular outcomes trial august 2025 Pipeline Update: - Prime Therapeutics GLP-1 Receptor Agonists in Heart

But in some cases, these common side effects can be more severe

These milestones are designed to evaluate Revita as the first potential therapy for post-GLP-1 weight maintenance and to open a new therapeutic category in obesity care

These data suggest that we might indeed have hyper-activity of pyrimidine salvage

Both analyses were performed using the same methods as the primary analysis

LOCATIONS Newtown, CT Fairfield, CT Proudly serving Fairfield County, New Haven County and the surrounding areas for 15 years PATIENT CARE Patient Portal Office Policies Privacy Policy Contact Us Payment Plans All Rights Reserved